Dr Ching-Hsien Chen

Department of Internal Medicine, University of California Davis, Davis, CA, USA

Dr. Ching-Hsien Chen is an Associate Professor at the University of California, Davis (UC Davis), and the Director of the Interstitial Lung Disease Biobank at the UC Davis School of Medicine. She earned her PhD in Molecular and Cellular Biology and completed postdoctoral training in Molecular Cancer Biology. Dr. Chen's research focuses on elucidating the mechanisms of disease progression in cancer and fibrosis, with a particular emphasis on target identification and therapeutic discovery. Her work combines advanced molecular techniques with translational approaches, targeting aberrant cell signaling and metabolic reprogramming. Dr. Chen's research has been continuously supported by prestigious U.S. federal agencies, including the National Institutes of Health (NIH) and the Department of Defense (DoD), and has garnered recognition through numerous awards, including her designation as a UC Davis Chancellor's Fellow.

Beyond her research, Dr. Chen actively contributes to the scientific community through her participation in grant review panels (e.g., the NIH, the DoD, and the Nebraska Cancer and Smoking Disease Research Program) and as an abstract reviewer for several international conferences. She has also served as a Guest Editor for Frontiers in Physiology and a Review Editor for Frontiers in Cell and Developmental Biology. Dr. Chen has authored numerous high-impact publications, holds multiple patents for innovative therapeutic approaches, and continues to play a pivotal role in advancing translational research for disease-targeted therapies.

Updated 18 December 2024